BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 18035923)

  • 1. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. eComment: Anticoagulation for mechanical heart valves: a current assessment.
    Koniari I
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):264-5. PubMed ID: 19164312
    [No Abstract]   [Full Text] [Related]  

  • 5. Anticoagulation after bioprosthetic aortic valve replacement.
    Nowell J; Jahangiri M
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1201-2; author reply 1202. PubMed ID: 20951265
    [No Abstract]   [Full Text] [Related]  

  • 6. Is early antithrombotic therapy necessary in bioprosthetic valves?
    Mestres CA; Aramendi JI
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):724-5; author reply 725-6. PubMed ID: 20723739
    [No Abstract]   [Full Text] [Related]  

  • 7. Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
    Buchanan-Leel B; Levetan BN; Lombard CJ; Commerford PJ
    J Heart Valve Dis; 2002 Jul; 11(4):583-92; discussion 593. PubMed ID: 12150309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of mitral valve replacement: biological xenograft versus mechanical valves.
    Yao H; Miyamoto T; Mukai S; Yamamura M; Tanaka H; Nakagawa T; Ryomoto M; Inai Y; Yoshioka Y; Kaji M
    J Artif Organs; 2003; 6(1):30-6. PubMed ID: 14598122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eComment: Mechanical valve replacement in the elderly: does anticoagulation have benefit?
    Gunay R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):581-2. PubMed ID: 19773234
    [No Abstract]   [Full Text] [Related]  

  • 10. Choice of prosthetic heart valve in adults an update.
    Rahimtoola SH
    J Am Coll Cardiol; 2010 Jun; 55(22):2413-26. PubMed ID: 20510209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical aortic valve without anticoagulation for twenty-three years.
    Sharma S; McMurty K; Chalapathy N; Ameen A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):263-4. PubMed ID: 19017749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What type of valve replacement should be used in patients with endocarditis?
    Newton S; Hunter S
    Interact Cardiovasc Thorac Surg; 2010 Dec; 11(6):784-8. PubMed ID: 20713537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical tricuspid valve replacement is not superior in patients younger than 65 years who need long-term anticoagulation.
    Hwang HY; Kim KH; Kim KB; Ahn H
    Ann Thorac Surg; 2012 Apr; 93(4):1154-60. PubMed ID: 22365259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
    Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seven-year results with the St Jude Medical Silzone mechanical prosthesis.
    Jamieson WR; Fradet GJ; Abel JG; Janusz MT; Lichtenstein SV; MacNab JS; Stanford EA; Chan F
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1109-15.e2. PubMed ID: 19379975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aortic valve replacement dilemma: mechanical or biological prosthesis?
    Cannata A; Russo CF; Taglieri C
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1101-2; author reply 1102. PubMed ID: 18954665
    [No Abstract]   [Full Text] [Related]  

  • 18. The valve of choice in elderly patients and its influence on quality of life: a long-term comparative study.
    Kurlansky PA; Williams DB; Traad EA; Carrillo RG; Schor JS; Zucker M; Ebra G
    J Heart Valve Dis; 2006 Mar; 15(2):180-9; discussion 190. PubMed ID: 16607898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.
    Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C
    J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes?
    Alsoufi B; Manlhiot C; McCrindle BW; Canver CC; Sallehuddin A; Al-Oufi S; Joufan M; Al-Halees Z
    Eur J Cardiothorac Surg; 2009 Jul; 36(1):84-90; discussion 90. PubMed ID: 19369085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.